Women's health findings presented at national conference

sions and organ failure. Although intravenous infusion of magnesium sulfate can decrease the likelihood that a woman with preeclampsia will develop eclamptic seizures, the only effective treatment for the syndrome is immediate delivery, which can be dangerous for the baby if it is too early in the pregnancy.

"We found that levels of CRP were doubled in postmenopausal women who had a prior episode of eclampsia compared to those who had a history of normal pregnancies," said Carl Hubel, Ph.D., lead author, assistant professor of obstetrics, gynecology and reproductive sciences and environmental and occupational health at the University of Pittsburgh School of Medicine and an MWRI assistant investigator. "The finding is even more striking because this difference remained after adjusting for other, potentially confounding risk factors such as age, weight, smoking and use of hormone-replacement therapy."

The finding indicates that pregnancy outcome could be viewed as "a natural early stress test" for future risk of cardiovascular disease the leading cause of death for women. "We propose that prior preeclampsia particularly severe preeclampsia be considered as a red flag to identify women of reproductive age who stand to benefit from cardiovascular risk factor modification," said Dr. Hubel. "If we can identify these differences during a woman's reproductive years and intervene with lifestyle changes early and aggressively, we may be able to impact her future risk. Early screening here is vital."

For the current study, Dr. Hubel and his colleagues compared data available from a previous study on 25 Icelandic women with prior eclampsia and 28 Icelandic women with normal pregnancies. Additional authors include Robert Powers, Ph.D.; Hilary Gammill, M.D.; James Roberts, M.D.; and Roberta Ness, M.D., M.P.H., all of the University of Pittsburgh; and Sunna Snaedal, M.D., Karolinska University Hospital, Stockholm, Sweden; and Reynir Arngrimsson, Ph.D., U


Page: 1 2 3 4

Related biology news :

1. Brandeis and Brigham and Womens Hospital license technology for Gauchers to Amicus Therapeutics
2. Womens skin tone influences perception of beauty, health and age
3. Womens math performance affected by theories on sex differences: UBC researchers
4. Womens Bioethics Project unveils The Scientist & the Ethicist podcast series
5. Womens bioethics project receives grant from Ford Foundation
6. 2006 SGO Annual Meeting on Womens Cancer
7. Womens health study finds vitamin E does not protect women from heart attack, stroke, or cancer
8. Womens health, tissue regeneration is focus of Illinois & Carle Hospital initiative
9. Particle emissions from laser printers might pose health concern
10. Cell damage caused by brushing may help keep gums healthy
11. New studies on goats milk show it is more beneficial to health than cows milk

Post Your Comments:

(Date:6/23/2020)... ... June 23, 2020 , ... In its June 22 online post, business and ... L. Sherley, M.D., Ph.D., founder and director of stem cell biotechnology company Asymmetrex ... 16 that starting July 5 it would begin offering free tissue stem ...
(Date:6/13/2020)... , ... June 11, 2020 , ... ... services, announces a significant expansion of its forensic genealogy team. Bode’s Forensic ... attorneys through proven forensic genealogy and DNA analysis methods. The team has added ...
(Date:6/5/2020)... ... 2020 , ... “Although we are disappointed to have to make this decision ... the public. We remain committed to creating a global platform to showcase the ... Sutcliffe, President of WMIS. , The abstract deadline for the virtual ...
Breaking Biology News(10 mins):
(Date:5/26/2020)... PARK, Calif. (PRWEB) , ... May 26, 2020 , ... ... , the most recognized brand of smart garage door openers, announce a new integration ... line of Wi-Fi enabled garage door openers powered by Aladdin Connect® can now be ...
(Date:5/21/2020)... CITY, Calif. (PRWEB) , ... May 20, 2020 ... ... announce the addition of Simon Prakash, who will serve as the company’s executive ... joins at a time when Exo is disrupting the medical imaging space, bringing ...
(Date:5/15/2020)... ... ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, ... continue to lead Sentien’s Board of Directors, a role he has filled for the ... management team. , Mr. Ganz has more than 30 years of experience ...
(Date:5/14/2020)... ... May 13, 2020 , ... Early ... readouts, providing little or no information on the drug’s mechanism of action (MOA). ... of compounds by measuring the activity of molecular pathways. This information can complement ...
Breaking Biology Technology:
Cached News: